The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 642.00
Bid: 638.00
Ask: 646.00
Change: 10.00 (1.58%)
Spread: 8.00 (1.254%)
Open: 636.00
High: 642.00
Low: 636.00
Prev. Close: 632.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

9 Jul 2020 10:58

RNS Number : 5554S
Intl. Biotechnology Trust PLC
09 July 2020
 

International Biotechnology Trust: New research

09/07/2020

IBT offers a differentiated exposure to a secular growth theme complemented by a solid yield…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEANXNESKEEEA
Date   Source Headline
28th Jul 202311:47 amPRNNet Asset Value(s)
27th Jul 202311:51 amPRNNet Asset Value(s)
26th Jul 20235:04 pmRNSTransaction in Own Shares
26th Jul 202310:46 amPRNNet Asset Value(s)
26th Jul 20238:00 amRNSPortfolio Update
25th Jul 202312:16 pmPRNNet Asset Value(s)
24th Jul 202311:22 amPRNNet Asset Value(s)
21st Jul 202311:08 amPRNNet Asset Value(s)
20th Jul 202310:57 amPRNNet Asset Value(s)
19th Jul 20235:40 pmRNSTransaction in Own Shares
19th Jul 202311:26 amPRNNet Asset Value(s)
18th Jul 202311:41 amPRNNet Asset Value(s)
17th Jul 20235:19 pmRNSTransaction in Own Shares
17th Jul 202310:43 amPRNNet Asset Value(s)
14th Jul 202311:01 amPRNNet Asset Value(s)
14th Jul 20239:23 amPRNNet Asset Value(s)
12th Jul 20231:28 pmPRNNet Asset Value(s)
11th Jul 20234:35 pmRNSTransaction in Own Shares
11th Jul 202311:47 amPRNNet Asset Value(s)
10th Jul 20235:00 pmRNSTransaction in Own Shares
10th Jul 202312:02 pmPRNNet Asset Value(s)
10th Jul 202310:40 amEQSHardman & Co Research on International Biotechnology Trust (IBT): Industry M&A remains a key driver
7th Jul 20235:31 pmRNSTransaction in Own Shares
7th Jul 202310:27 amPRNNet Asset Value(s)
6th Jul 20235:21 pmRNSTransaction in Own Shares
6th Jul 202310:48 amPRNNet Asset Value(s)
5th Jul 20236:04 pmRNSDividend Declaration
5th Jul 20235:26 pmRNSTransaction in Own Shares
5th Jul 20234:22 pmRNSDirector Declaration
5th Jul 202310:01 amPRNNet Asset Value(s)
4th Jul 202310:42 amPRNNet Asset Value(s)
3rd Jul 20234:55 pmRNSTransaction in Own Shares
3rd Jul 202310:10 amPRNNet Asset Value(s)
3rd Jul 202310:09 amRNSBlock listing Interim Review
3rd Jul 202310:07 amRNSTotal Voting Rights
30th Jun 20234:57 pmRNSTransaction in Own Shares
30th Jun 202310:10 amPRNNet Asset Value(s)
29th Jun 202310:54 amPRNNet Asset Value(s)
28th Jun 20234:59 pmRNSTransaction in Own Shares
28th Jun 202310:42 amPRNNet Asset Value(s)
27th Jun 20234:21 pmRNSTransaction in Own Shares
27th Jun 202310:31 amPRNNet Asset Value(s)
26th Jun 20235:16 pmRNSTransaction in Own Shares
26th Jun 202310:40 amPRNNet Asset Value(s)
23rd Jun 20235:12 pmRNSTransaction in Own Shares
23rd Jun 202310:33 amPRNNet Asset Value(s)
22nd Jun 202310:48 amPRNNet Asset Value(s)
22nd Jun 20238:00 amRNSPortfolio Update
21st Jun 20234:44 pmRNSTransaction in Own Shares
21st Jun 202310:30 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.